Pub fees email yes from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

Authors :: Susan N. Chi
Sudha Parasuraman
Jason R. Dobson
Suraj G. Bhansali
Alessandro Matano
Marlyane Motta
Giles W. Robinson
Thomas Cash
Shakeel Modak
Andrew D.J. Pearson
Aurélien Marabelle
Nicholas G. Gottardo
James I. Geller
Matthias Fischer
Steven G. DuBois
Franck Bourdeaut
Birgit Geoerger
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Pub fees email yes

Tools